1-3 of 3
Monica Schaller, PhD
Close
Sort by
Journal Articles

High-Throughput Screening of a Large Combinatorial Library of Small Proteins Against Human Spleen-Derived Monoclonal Anti-ADAMTS13 Antibodies Yields Specific Anti-Idiotypic Molecules – Potential Tools for New Treatment Strategy in Acquired TTP

Monica Schaller, PhD, Sabine Hiltbrunner, Irmela Sulzer, Monique Vogel, PhD, Karim Kentouche, MD, Bernhard Laemmle, MD, Johanna A. Kremer Hovinga
Journal: Blood
Blood (2012) 120 (21): 487.
https://doi.org/10.1182/blood.V120.21.487.487
Published: 2012
Journal Articles

Anti-ADAMTS13 Inhibitor Boosting During Plasma Exchange Therapy in Acquired TTP Is the Expression of a General Dysregulation of the Immune Response,

Monica Schaller, PhD, Irmela Sulzer, Magnus Mansouri, MD student, Bernhard Lämmle, MD, Johanna A. Kremer Hovinga Strebel, MD
Journal: Blood
Blood (2011) 118 (21): 3299.
https://doi.org/10.1182/blood.V118.21.3299.3299
Published: 2011
Journal Articles

Inhibitory Spleen-Derived Anti-ADAMTS13 Antibodies Are Characterized by a Limited Number of Variable Heavy Chain CDR3 Signatures in Patients with Relapsing Acquired Thrombotic Thromobocytopenic Purpura

Monica Schaller, PhD, Gianna Tanno, Irmela Sulzer, Monique Vogel, PhD, Karim Kentouche, MD, Bernhard Laemmle, MD, Johanna A. Kremer Hovinga Strebel, MD
Journal: Blood
Blood (2011) 118 (21): 194.
https://doi.org/10.1182/blood.V118.21.194.194
Published: 2011